This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2023 results reflect sales growth in the North America and International regions due to solid pricing. Management reaffirms the adjusted EBITDA and adjusted EPS guidance for 2023.
Colgate (CL) Q2 Earnings & Sales Surpass Estimates, View Up
by Zacks Equity Research
Colgate-Palmolive's (CL) second-quarter 2023 organic sales advance 8%, with improvements in all divisions and categories.
Procter & Gamble (PG) Rises on Q4 Earnings Beat, Robust View
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results reflect strong gains from its pricing actions, robust demand, improved sales and margins, and a positive product mix.
Church & Dwight (CHD) Ups View on Q2 Earnings & Sales Beat
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2023 results reflect strength in the company's brands, robust consumption gains and pricing. Management raises the 2023 view again.
Church & Dwight (CHD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Church & Dwight (CHD) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Church & Dwight (CHD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 16.46% and 2.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Top-Rated Stocks to Watch as Earnings Approach
by Shaun Pruitt
Investors should pay attention to other sectors outside of Energy on Friday as there appears to be opportunity in these Consumer Staples and Auto sector stocks.
Keurig Dr Pepper (KDP) Q2 Earnings Top Estimates, Sales View Up
by Zacks Equity Research
Keurig Dr Pepper's (KDP) second-quarter 2023 results reflect increases in sales and earnings, driven by continued brand strength and significant pricing.
Why Earnings Season Could Be Great for Church & Dwight (CHD)
by Zacks Equity Research
Church & Dwight (CHD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors Likely to Influence Diageo's (DEO) FY23 Earnings
by Zacks Equity Research
Diageo's (DEO) fiscal 2023 results are expected to reflect gains from its effective marketing, strong commercial execution and favorable industry trends of premiumization.
Is a Beat in Store for Molson Coors (TAP) in Q2 Earnings?
by Zacks Equity Research
Despite inflation, Molson Coors' (TAP) second-quarter results are expected to reflect strength in core brands, a revitalization plan and the premiumization of its global portfolio.
Altria Group (MO) Queues for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Altria Group's (MO) second-quarter results are likely to reflect gains from pricing and strength in Oral Tobacco Products, though soft cigarette volumes have been a concern.
What to Note Ahead of Service Corp's (SCI) Q2 Earnings?
by Zacks Equity Research
Service Corp's (SCI) second-quarter 2023 performance is likely to have been affected by inflationary pressure. Strength in the preened cemetery sales has been an upside.
Factors to Note Ahead of Sysco Corporation's (SYY) Q4 Earnings
by Zacks Equity Research
Sysco's (SYY) fiscal fourth-quarter earnings is likely to reflect gains from the Recipe for Growth initiative. However, rising cost inflation might have been a hurdle.
Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.
Albertsons (ACI) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Albertsons' (ACI) fiscal first-quarter results showcase the robustness of its business and the success of the Customers for Life transformation strategy amid increasing economic challenges.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Procter & Gamble (PG) is Poised for Q4 Earnings Beat
by Zacks Equity Research
Procter & Gamble's (PG) unwavering commitment to leverage its brand strength and adopt effective strategies has been bolstering its organic sales and market position.
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Colgate (CL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) second-quarter 2023 sales are likely to have benefited from strong demand for its products, innovation, brand strength and a focus on premiumization. Rising costs and expenses might have hurt its margins.
Factors Likely to Decide Newell's (NWL) Fate in Q2 Earnings
by Zacks Equity Research
The ongoing tough environment, reduced inventory and inflationary pressures are likely to have dented Newell's (NWL) Q2 earnings despite productivity and efficiency initiatives.
Factors to Note Ahead of FEMSA's (FMX) Upcoming Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from continued strength in OXXO Mexico and OXXO Gas, expansion into newer businesses, and digital initiatives amid cost woes.
Will Soft Shipment Trend Mar Boston Beer's (SAM) Q2 Earnings?
by Zacks Equity Research
Boston Beer's (SAM) Q2 results are expected to reflect the continued impacts of declining shipments and depletions, and challenges in the hard seltzer category.
Mondelez (MDLZ) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Mondelez's (MDLZ) second-quarter 2023 performance is likely to gain from effective pricing actions and prudent buyouts. Strength in the company's snacking category is an upside.
Is a Beat in Store for Church & Dwight (CHD) in Q2 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter results are likely to reflect gains from pricing, innovation and demand amid elevated costs.